| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |